Evidence map›Paper›PMID 37006808›Full record

ArticleJournal of inflammation research2023

Association of Neutrophil-to-Lymphocyte Ratio with Nutrition in Patients with Various Types of Malignant Tumors: A Multicenter Cross-Sectional Study.

Lihua Kang, Xiangliang Liu, Wei Ji, Kaiwen Zheng, Yuguang Li, Yanqiu Song, Hua He, Xiaomeng Wang, Tingting Yang, Meng Guan and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Lihua KangCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Xiangliang LiuCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Wei JiCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Kaiwen ZhengCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.ORCID 0000-0001-9801-4897
Yuguang LiCollege of Instrumentation and Electrical Engineering, Jilin University, Changchun, Jilin Province, People's Republic of China.
Yanqiu SongCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.ORCID 0000-0002-1326-1416
Hua HeCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Xiaomeng WangCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Tingting YangCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Meng GuanCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Ge ZhuCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Yangyang GaoCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Yanjie GuanCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Lei WangCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Wei LiCancer Center, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Neutrophil-to-lymphocyte ratio (NLR) is an index of systemic inflammation. This study is to clarify the role of NLR in body functional status, nutritional risk and nutritional status in the course of tumor. Methods: A multi-center cross-sectional study of patients with various types of malignant tumors was accrued from the whole country. There were 21,457 patients with completed clinical data, biochemical indicators, physical examination, the Patient-Generated Subjective Global Assessment (PG-SGA) and Nutrition Risk Screening 2002 (NRS2002) survey. Logistic regression analysis was used to figure out the influencing factors of NLR, and four models were established to evaluate the influence of NLR on body functions, nutritional risks and nutritional status. Results: Male patients, TNM stage IV, total bilirubin, hypertension and coronary atherosclerotic heart disease (CAHD) were independent predictors of NLR >2.5. BMI, digestive systemic tumors and triglyceride negatively affect NLR in multivariable logistic regression. NLR was an independent predictor of Karnofsky Performance Scale (KPS), fat store deficit in all degrees, moderate and severe muscle deficit, mild fluid retention and PG-SGA grade. Conclusion: Male patients and those with hypertension and CAHD are prone to systemic inflammation. Systemic inflammation significantly degrades body function status and nutritional status, increases nutritional risk and influences fat and muscle metabolism in patients with malignant tumor. Improving the intervenable indicators such as elevating albumin and pre-albumin, decreasing total bilirubin and enhancing nutrition support are imperative. Obesity and triglyceride behave like anti-systemic inflammation, which is misleading due to reverse causation in the course of malignancy.

Indexed as

body functioninflammationneutrophil-to-lymphocyte rationutritiontumor

Identifiers

PMID37006808
PMCPMC10064873
OpenAlexW4361005611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.